ES2182137T3 - Empleo de mezclas de productos activos, que contienen fitoestenoles y/o esteres de fitoestenol y agentes potenciadores para la obtencion de agentes hipocolesterinemicos. - Google Patents

Empleo de mezclas de productos activos, que contienen fitoestenoles y/o esteres de fitoestenol y agentes potenciadores para la obtencion de agentes hipocolesterinemicos.

Info

Publication number
ES2182137T3
ES2182137T3 ES97951916T ES97951916T ES2182137T3 ES 2182137 T3 ES2182137 T3 ES 2182137T3 ES 97951916 T ES97951916 T ES 97951916T ES 97951916 T ES97951916 T ES 97951916T ES 2182137 T3 ES2182137 T3 ES 2182137T3
Authority
ES
Spain
Prior art keywords
agents
esteres
mixtures
phytesthenols
phytesthenol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97951916T
Other languages
English (en)
Inventor
Norbert Weitkemper
Bernd Fabry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Personal Care and Nutrition GmbH
Original Assignee
Cognis Deutschland GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26031678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2182137(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19700796A external-priority patent/DE19700796C2/de
Application filed by Cognis Deutschland GmbH and Co KG filed Critical Cognis Deutschland GmbH and Co KG
Application granted granted Critical
Publication of ES2182137T3 publication Critical patent/ES2182137T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PARA FABRICAR AGENTES HIPOCOLESTEROLEMICOS SE PROPONE LA UTILIZACION DE MEZCLAS DE PRINCIPIOS ACTIVOS, QUE CONTIENEN (A) FITOSTENOLES Y/O ESTERES DE FITOSTENOL, Y (B) AGENTES DE POTENCIACION, ELEGIDOS DEL GRUPO FORMADO POR QUITOSANOS, SULFATOS DE FITOSTENOL Y/O ACIDOS (DESOXI)RIBONUCLEICOS. AUNQUE LOS AGENTES DE POTENCIACION MISMOS NO POSEEN NADA DE O SOLO UN POQUITO DE ACCION HIPOCOLESTEROLEMICA, ELEVAN LA VELOCIDAD CON LA CUAL LOS ESTERES DE FITOSTENOL BAJAN EL CONTENIDO EN COLESTEROL EN EL SUERO. SI SE ENCAPSULAN EN GELATINA SE PUEDEN TOMAR LOS AGENTES SIN PROBLEMA TAMBIEN POR VIA ORAL EN DOSIS ELEVADAS.
ES97951916T 1996-11-28 1997-11-19 Empleo de mezclas de productos activos, que contienen fitoestenoles y/o esteres de fitoestenol y agentes potenciadores para la obtencion de agentes hipocolesterinemicos. Expired - Lifetime ES2182137T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19649286 1996-11-28
DE19700796A DE19700796C2 (de) 1996-11-28 1997-01-13 Wirkstoffmischungen zur Verminderung des Cholesteringehaltes im Serum von Warmblütern

Publications (1)

Publication Number Publication Date
ES2182137T3 true ES2182137T3 (es) 2003-03-01

Family

ID=26031678

Family Applications (2)

Application Number Title Priority Date Filing Date
ES97950201T Expired - Lifetime ES2176805T3 (es) 1996-11-28 1997-11-19 Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos.
ES97951916T Expired - Lifetime ES2182137T3 (es) 1996-11-28 1997-11-19 Empleo de mezclas de productos activos, que contienen fitoestenoles y/o esteres de fitoestenol y agentes potenciadores para la obtencion de agentes hipocolesterinemicos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES97950201T Expired - Lifetime ES2176805T3 (es) 1996-11-28 1997-11-19 Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos.

Country Status (10)

Country Link
US (1) US6383514B1 (es)
EP (2) EP0952837B1 (es)
JP (2) JP2001508046A (es)
AU (2) AU713665B2 (es)
CA (2) CA2273341A1 (es)
DK (2) DK0952837T3 (es)
ES (2) ES2176805T3 (es)
NO (2) NO992564D0 (es)
NZ (1) NZ335990A (es)
WO (2) WO1998023277A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1001951A1 (en) * 1991-05-03 1998-07-24 Raisio Benecol Ltd. A substance for lowering high cholesterol level in serum and a method for preparing the same
DE19750422C1 (de) * 1997-11-14 1998-11-26 Henkel Kgaa Verwendung von ausgewählten Phytostenolestern zur Herstellung von hypocholesterinämischen Mitteln
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
DE59908424D1 (de) * 1999-07-02 2004-03-04 Cognis Iberia Sl Mikrokapseln - I
US6677327B1 (en) 1999-11-24 2004-01-13 Archer-Daniels-Midland Company Phytosterol and phytostanol compositions
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513881D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US20080182801A1 (en) * 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
EP1600062A1 (en) * 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions comprising prebiotics and sterols
GB0512726D0 (en) * 2005-06-22 2005-07-27 Btg Int Ltd Multiple sclerosis therapy and diagnosis
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
JP2010509355A (ja) * 2006-11-06 2010-03-25 ジャイナ ファーマシューティカルズ，インコーポレーテッド グッグルリン脂質の方法および組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085939A (en) 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3203862A (en) 1960-03-11 1965-08-31 Jones John Harris Oral anti-hypercholesterol composition
US3089939A (en) 1960-04-06 1963-05-14 Kamborian Dip-type adhesive container
CA928140A (en) 1969-07-17 1973-06-12 A. Erickson Billy Clear cooking and salad oils having hypocholesterolemic properties
JPS57206336A (en) * 1981-06-12 1982-12-17 Ajinomoto Co Inc Edible oil
CA1185500A (en) 1981-08-12 1985-04-16 Joseph Z. Zdrok Disposable respirator
DE3672270D1 (de) 1985-03-06 1990-08-02 Yoshikawa Oil & Fat Verfahren zur herstellung von fettsaeureestern.
JPS62186936A (ja) 1986-02-13 1987-08-15 Asahi Denka Kogyo Kk ステリン乳化乃至可溶化組成物
FR2620024B1 (fr) 1987-09-09 1991-03-15 Dermatologiques Et Composition cosmetique comportant un agent antiradicaux libres, et agent correspondant
US5362732A (en) * 1989-12-20 1994-11-08 University Of North Carolina At Chapel Hill Boronated compounds
HK1001951A1 (en) 1991-05-03 1998-07-24 Raisio Benecol Ltd. A substance for lowering high cholesterol level in serum and a method for preparing the same
US5352458A (en) 1992-12-21 1994-10-04 Applied Genetics Inc. Tanning method using DNA repair liposomes
KR970008132B1 (ko) 1993-02-08 1997-05-21 전동원 생체 임상의학용 키틴 및 키토산 제조방법
US5470577A (en) 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
DE4323615A1 (de) 1993-07-12 1995-01-19 Schreiner Edelgard Mittel gegen vorzeitiges Altern der Haut
DE4442987C2 (de) 1994-12-02 1997-04-17 Henkel Kgaa Kationische Chitinabbauprodukte

Also Published As

Publication number Publication date
DK0941097T3 (da) 2002-08-19
NZ335990A (en) 2000-10-27
NO992562L (no) 1999-05-27
NO992564L (no) 1999-05-27
JP2001508046A (ja) 2001-06-19
US6383514B1 (en) 2002-05-07
AU713665B2 (en) 1999-12-09
EP0941097B1 (de) 2002-05-02
JP2001504505A (ja) 2001-04-03
EP0952837A1 (de) 1999-11-03
CA2273341A1 (en) 1998-06-04
AU714993B2 (en) 2000-01-13
AU5322998A (en) 1998-06-22
NO992564D0 (no) 1999-05-27
EP0941097A1 (de) 1999-09-15
WO1998023277A1 (de) 1998-06-04
EP0952837B1 (de) 2002-09-18
WO1998023275A1 (de) 1998-06-04
ES2176805T3 (es) 2002-12-01
DK0952837T3 (da) 2003-01-27
AU5553198A (en) 1998-06-22
CA2272754A1 (en) 1998-06-04
NO992562D0 (no) 1999-05-27

Similar Documents

Publication Publication Date Title
ES2182137T3 (es) Empleo de mezclas de productos activos, que contienen fitoestenoles y/o esteres de fitoestenol y agentes potenciadores para la obtencion de agentes hipocolesterinemicos.
NO20003698D0 (no) Orale sammensetninger
FI870343L (fi) Foerfarande foer expression av gener i vaexter, i vaextdelar och i vaextcellkulturer samt dna-fragmenter, plasmider och transformerade mikroorganismer foer anvaendning vid foerfarandet.
EE04576B1 (et) Suposiit happes ebapüsivate toimeainete tarbeks, selle valmistamismeetod, toimeaineühik ja selle valmistamismeetod ning preparaat
SE7611379L (sv) Antihypertensiva medel
IL56369A (en) Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
ES2145557T3 (es) Composiciones de ablandamiento del agua y composiciones detergentes.
MA21264A1 (fr) Composition permettant d'administrer un medicament sous forme de gellules, d'une poudre ou d'un liquide.
AR029190A1 (es) Composiciones que contienen derivados del acido hidroxieicosatetraenoico y uso para la manufactura de un medicamento en el tratamiento de trastornos del ojo seco
SV2002000969A (es) Composicion parenteral reconstituible
NO964433D0 (no) Farmasöytiske preparater på basis av derivater av taxanklassen
ES8900007A1 (es) Un metodo para producir normas orales frente a virus de hepatitis-b.
ATE326985T1 (de) Lyophilisierte pharmazeutische zusammensetzung von propofol
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
ES481720A1 (es) Procedimiento para la obtencion de celulosa.
FI860602A0 (fi) Anordning foer foersaettande i vertikal roerelse av en sits, isynnerhet en patientstol.
EA200000552A1 (ru) Готовые препаративные формы, содержащие растворенный пароксетин
BR9106272A (pt) Composicoes farmaceuticas contendo ipriflavona,processo para sua preparacao e uso terapeutico relativo
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
ES2039460T3 (es) Un procedimiento para producir una solucion inyectable de glicosido de antraciclina.
FI873952L (fi) Anordning foer avlaegsnande av pulverformigt material som samlas i den roerformiga bakdelen vid tillverkning av en optisk fibers aemne.
OA08165A (fr) Nouveaux dérivés thiosulfonates, leur procédé de préparation ainsi que les compositions pharmaceutiques les contenant.
AR009995A1 (es) Composicion detergente granulada que comprende la enzima isopeptidasa
AU3868895A (en) Process for the preparation of furosemide
IT8025850A0 (it) Coadiuvante per promuovere l'absorbimento di sostanze farmacologicamente attive attraverso il retto, e composizione farmaceutica che lo comprendono.